Burning Rock Biotech Limited
Market Cap
$20.13M
P/E Ratio
-10.45
EPS
$-1.79
Dividend Yield
0.00%
52-Week Range
$2.18 — $41.72
Volume
9.22K
Avg Volume
27.21K
Beta
1.45
P/E (TTM)
-10.45
Forward P/E
—
PEG Ratio
-0.07
P/S (TTM)
0.22
P/B (TTM)
0.22
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.21%
ROA (TTM)
-0.15%
ROIC
—
Gross Margin
0.73%
Operating Margin
-0.23%
Net Margin
—
Debt/Equity
0.06
Current Ratio
3.14
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.19%
EPS Growth (5Y)
+0.19%
Sales Growth (3Y)
+0.01%
Sales Growth (5Y)
+0.07%
EPS Est (This Year)
—
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$430.89
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
1.08M
Float
901.20K
Free Float %
83.70%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
CN
Exchange
NASDAQ
IPO Date
2020-06-12
Employees
674
CEO
Yusheng Han
Index Membership
—
Website
https://www.brbiotech.com
Burning Rock Biotech Limited (BNR) is a healthcare company in the medical - diagnostics & research industry listed on the NASDAQ. With a market capitalization of $20.13M, a P/E ratio of -10.45, BNR is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare BNR against other stocks using dozens of fundamental and technical filters.
Burning Rock Biotech Limited (BNR) has a trailing twelve-month (TTM) P/E ratio of -10.45. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Burning Rock Biotech Limited (BNR) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Burning Rock Biotech Limited (BNR) has a market capitalization of $20.13 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.